MedPath

Prophylactic swallowing exercise program in head and neck cancer patients

Not Applicable
Completed
Conditions
Head and neck cancer treated with radiotherapy or concomitant chemoradiotherapy
Cancer
Malignant neoplasm of head and neck treated with radiotherapy or concomitant chemoradiotherapy
Registration Number
ISRCTN98243550
Lead Sponsor
Antwerp University Hopsital
Brief Summary

2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32122397 protocol (added 04/03/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36121560/ (added 20/09/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37550571/ Effect of service-delivery mode and overall adherence level (added 09/08/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

1. Newly diagnosed squamous cell carcinoma of the oropharynx
2. Stage III or IV cancer (according to TNM-7 classification)
3. Treatment with radiotherapy or concomitant chemoradiotherapy with/without induction chemotherapy
4. Demonstrating sufficient cognitive and language abilities

Exclusion Criteria

1. Recurrent carcinoma or metastasis from a non-HNC (head and neck cancer) carcinoma
2. Previous radiotherapy and/or chemoradiotherapy ,or surgery in head-neck region with possible impact on swallowing function

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Current primary outcome measure as of 15/02/2019:<br>Swallowing function assessed , using the Mann Assessment of Swallowing Ability – Cancer (MASA-C) at baseline, during the first 4 weeks of treatment, at the end of treatment, and 1 and 3 months after treatment<br><br>Previous primary outcome measure:<br>Degree of compliance, assessed weekly during the first 4 weeks of treatment, assessed using:<br>1. The total performed number of exercises per week, assessed by:<br>1.1. Daily patient (group 1 and group 2) and therapist (group 3) log book of performed exercises<br>1.2. IOPI device (group 2 and group 3) for tongue strengthening exercises<br>2. Time spent on the app per day (for group 2 only), automatically registered
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath